Eticovo — Medical Mutual
Still’s Disease
Initial criteria
- Patient age > 18 years
 - Tried one corticosteroid
 - Tried one DMARD for ≥ 2 months or was intolerant OR has trial of one biologic other than requested drug
 - Medication prescribed by or in consultation with rheumatologist
 - Site of care medical necessity is met
 
Reauthorization criteria
- Patient established on etanercept therapy for ≥ 6 months
 - Beneficial clinical response by objective measures (resolution of fever, improved rash, improved markers, steroid sparing) OR symptomatic improvement (joint pain, stiffness, fatigue, function)
 - Site of care medical necessity is met
 
Approval duration
initial 6 months, reauth 1 year